Search Results

Effects of agmatine on radial-arm maze memory performance and autistic-like behaviors in a male rat model of autism.

• Authors : Parvan M; Department of Physiology and Pharmacology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.; Nozari M

Subjects: Agmatine*/Agmatine*/Agmatine*/pharmacology ; Disease Models, Animal* ; Maze Learning*/Maze Learning*/Maze Learning*/drug effects

• Source: Birth defects research [Birth Defects Res] 2024 Jul; Vol. 116 (7), pp. e2379.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101701004 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Agmatine modulation of gut-brain axis alleviates dysbiosis-induced depression-like behavior in rats.

• Authors : Rahangdale S; Division of Neuroscience, Department of Pharmacology, Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur, M.S., 441 002, India.; Deshmukh P

Subjects: Dysbiosis* ; Agmatine*/Agmatine*/Agmatine*/pharmacology ; Agmatine*/Agmatine*/Agmatine*/therapeutic use

• Source: European journal of pharmacology [Eur J Pharmacol] 2024 Oct 15; Vol. 981, pp. 176884. Date of Electronic Publication: 2024 Aug 10.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The prenatal use of agmatine prevents social behavior deficits in VPA-exposed mice by activating the ERK/CREB/BDNF signaling pathway.

• Authors : Chen S; Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; Xu Q

Subjects: Agmatine*/Agmatine*/Agmatine*/pharmacology ; Autism Spectrum Disorder*/Autism Spectrum Disorder*/Autism Spectrum Disorder*/chemically induced ; Autism Spectrum Disorder*/Autism Spectrum Disorder*/Autism Spectrum Disorder*/drug therapy

• Source: Birth defects research [Birth Defects Res] 2024 Apr; Vol. 116 (4), pp. e2336.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101701004 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Agmatine ameliorates valproic acid-induced depletion of parvalbumin-positive neuron.

• Authors : Khoram-Abadi KM; Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran.; Department of Anatomical Sciences, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Subjects: Agmatine*/Agmatine*/Agmatine*/therapeutic use ; Autism Spectrum Disorder*/Autism Spectrum Disorder*/Autism Spectrum Disorder*/chemically induced ; Parvalbumins*/Parvalbumins*/Parvalbumins*/metabolism

• Source: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience [Int J Dev Neurosci] 2024 Apr; Vol. 84 (2), pp. Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 8401784 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Pharmacological profile of agmatine: An in-depth overview.

• Authors : Rafi H; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Biochemistry, University of Karachi, Pakistan. Electronic address: .

Subjects: Agmatine*/Agmatine*/Agmatine*/pharmacology ; Agmatine*/Agmatine*/Agmatine*/metabolism; Humans

• Source: Neuropeptides [Neuropeptides] 2024 Jun; Vol. 105, pp. 102429. Date of Electronic Publication: 2024 Apr 03.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8103156 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice.

• Authors : Yun C; State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.; National Clinical Research Center for Obstetrics and Gynecology (Peking University Third Hospital), Beijing, China.

Subjects: Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/drug therapy ; Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/metabolism ; Agmatine*/Agmatine*/Agmatine*/pharmacology

• Source: Nature metabolism [Nat Metab] 2024 May; Vol. 6 (5), pp. 947-962. Date of Electronic Publication: 2024 May 20.Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits.

• Authors : Katariya RA; Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra 441002, India.; Sammeta SS

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology ; Agmatine*/Agmatine*/Agmatine*/pharmacology

• Source: Ageing research reviews [Ageing Res Rev] 2024 Apr; Vol. 96, pp. 102269. Date of Electronic Publication: 2024 Mar 11.Publisher: Elsevier Science Country of Publication: England NLM ID: 101128963 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Agmatine alleviates ethanol withdrawal-associated cognitive impairment and neurochemical imbalance in rats.

• Authors : Kale MB; Division of Neuroscience, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra 441002, India; SNJB's Shriman Sureshdada Jain College of Pharmacy, Neminagar, Chandwad, Nashik, Maharashtra 423101, India. Electronic address: .

Subjects: Agmatine*/Agmatine*/Agmatine*/pharmacology ; Agmatine*/Agmatine*/Agmatine*/therapeutic use ; Substance Withdrawal Syndrome*/Substance Withdrawal Syndrome*/Substance Withdrawal Syndrome*/metabolism

• Source: Neuroscience letters [Neurosci Lett] 2024 May 29; Vol. 832, pp. 137804. Date of Electronic Publication: 2024 Apr 30.Publisher: Elsevier Scientific Publishers Ireland Country of Publication: Ireland NLM ID: 7600130 Publication Model: Print-Electronic Cited Medium:

Record details

Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats.

• Authors : Katariya R; Division of Neuroscience, Department of Pharmacology, Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur, M.S. 441 002, India.; Mishra K

Subjects: Nitro Compounds*/Nitro Compounds*/Nitro Compounds*/toxicity ; Propionates*/Propionates*/Propionates*/toxicity ; Agmatine*/Agmatine*/Agmatine*/pharmacology

• Source: Neurotoxicology [Neurotoxicology] 2024 May; Vol. 102, pp. 12-28. Date of Electronic Publication: 2024 Mar 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 7905589 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The microbial metabolite agmatine induces polycystic ovary syndrome in mice.

Subjects: Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/metabolism ; Agmatine*/Agmatine*/Agmatine*/metabolism ; Agmatine*/Agmatine*/Agmatine*/pharmacology

• Source: Nature metabolism [Nat Metab] 2024 May; Vol. 6 (5), pp. 791-792.Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print Cited Medium: Internet ISSN: 2522-5812

Record details